Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AstraZeneca PLC Director's Dealing 2016

May 23, 2016

5229_dirs_2016-05-23_db0459ca-2934-4127-8c83-75533730e170.html

Director's Dealing

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0366Z

AstraZeneca PLC

23 May 2016

Transaction by Person Discharging Managerial Responsibilities

Disclosure Rule DTR 3.1.4

On 23 May 2016, the interest of Luke Miels, a person discharging managerial responsibilities, in AstraZeneca PLC Ordinary Shares of $0.25 each changed as detailed below.

The change in interest relates to the vesting on 23 May 2016 of an award of shares granted in September 2014 under the AstraZeneca Restricted Share Plan. In accordance with the terms of the award, Mr Miels has become beneficially entitled to all of the shares originally awarded.

Sufficient vested shares have been withheld to cover certain tax obligations arising on the vesting and the net number of shares has been delivered into a personal brokerage account.

Plan Shares awarded Shares vested Shares withheld Net shares received
AstraZeneca Restricted Share Plan 7,776 7,776 2,524 5,252

For tax purposes, the fair market value of the shares at vest was 3894.5 pence per share being the closing price of AstraZeneca shares on the last trading day preceding the vesting day.

A C N Kemp

Company Secretary

23 May 2016

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHUOUORNNAVUAR